PubMed
Nucleotide
Protein
Genome
Structure
PopSet
Taxonomy
OMIM
OMIM Update List for October, 2006
Please send your questions to the
NCBI Help Desk
.
October 31, 2006
New Entries:
610537
DIPEPTIDYL PEPTIDASE VII; DPP7
610538
UBIQUITIN-CONJUGATING ENZYME E2T; UBE2T
Clinical Synopsis for
610127
CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10
Changed Entries:
134370
COMPLEMENT FACTOR H; CFH
134371
COMPLEMENT FACTOR H-RELATED 1; CFHR1
138470
COMPLEMENT FACTOR B; CFB
139250
GROWTH HORMONE 1; GH1
172270
PHOSPHOGLYCERATE KINASE 2; PGK2
601118
CALCIUM-MODULATING CYCLOPHILIN LIGAND; CAMLG
602630
TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR; TGIF
602869
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; HNRPU
604591
PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; PBP
605336
COMPLEMENT FACTOR H-RELATED 3; CFHR3
605554
CD244 ANTIGEN; CD244
608603
GLIOMEDIN; GLDN
609412
EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8
609413
EXCISION-REPAIR CROSS-COMPLEMENTING, COMPLEMENTATION GROUP 6; ERCC6
610362
RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX-LIKE 1; RAXL1
610538
UBIQUITIN-CONJUGATING ENZYME E2T; UBE2T
Clinical Synopsis for
210600
SECKEL SYNDROME 1
Clinical Synopsis for
606693
KUFOR-RAKEB SYNDROME; KRS
Clinical Synopsis for
606858
PREMATURE CHROMOSOME CONDENSATION WITH MICROCEPHALY AND MENTAL RETARDATION
Clinical Synopsis for
607271
CASPASE 8 DEFICIENCY
Clinical Synopsis for
607330
LATHOSTEROLOSIS
Clinical Synopsis for
610127
CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10
October 30, 2006
New Entries:
610534
DECAPPING ENZYME, SCAVENGER; DCPS
610535
GLAUCOMA 1, OPEN ANGLE, M; GLC1M
610536
GROWTH AND MENTAL RETARDATION, MANDIBULOFACIAL DYSOSTOSIS, MICROCEPHALY,
Clinical Synopsis for
610535
GLAUCOMA 1, OPEN ANGLE, M; GLC1M
Changed Entries:
114290
CAMPOMELIC DYSPLASIA
125240
CD55 ANTIGEN; CD55
137750
GLAUCOMA 1, OPEN ANGLE, A; GLC1A
137760
GLAUCOMA, PRIMARY OPEN ANGLE; POAG
139139
NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NR4A1
154550
MANNOSEPHOSPHATE ISOMERASE; MPI
155145
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA
191170
TUMOR PROTEIN p53; TP53
229600
FRUCTOSE INTOLERANCE, HEREDITARY
248611
BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE; BCKDHB
249600
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE
600542
NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 3; NR4A3
600726
INDIAN HEDGEHOG; IHH
601828
NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2
601844
PROTEIN KINASE, LYSINE-DEFICIENT 4; WNK4
602429
GLAUCOMA 1, OPEN ANGLE, D; GLC1D
602579
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib
602919
DOCKING PROTEIN 1; DOK1
603383
GLAUCOMA 1, OPEN ANGLE, F; GLC1F
603969
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13B; TNFSF13B
604997
DOCKING PROTEIN 2; DOK2
606073
NADPH-DEPENDENT DIFLAVIN OXIDOREDUCTASE 1; NDOR1
606324
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7
606689
GLAUCOMA 1, OPEN ANGLE, B; GLC1B
606693
KUFOR-RAKEB SYNDROME; KRS
607463
PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13-LIKE; PPP1R13L
608160
SRY-BOX 9; SOX9
608695
GLAUCOMA 1, OPEN ANGLE, J; GLC1J
608696
GLAUCOMA 1, OPEN ANGLE, K; GLC1K
609309
MutS, E. COLI, HOMOLOG OF, 2; MSH2
609460
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME
609669
WD REPEAT-CONTAINING PROTEIN 36; WDR36
609745
GLAUCOMA 1, OPEN ANGLE, I; GLC1I
609887
GLAUCOMA 1, OPEN ANGLE, G; GLC1G
610513
ATPase, TYPE 13A2; ATP13A2
610535
GLAUCOMA 1, OPEN ANGLE, M; GLC1M
Clinical Synopsis for
229300
FRIEDREICH ATAXIA 1; FRDA
October 28, 2006
Changed Entries:
Clinical Synopsis for
608088
NEUROPATHY, HEREDITARY SENSORY, TYPE I, WITH COUGH AND GASTROESOPHAGEAL
October 27, 2006
New Entries:
300620
V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 1; VSIG1
610530
TRIPARTITE MOTIF-CONTAINING 41; TRIM41
610531
FAMILY WITH SEQUENCE SIMILARITY 126, MEMBER A; FAM126A
610532
HYPOMYELINATION AND CONGENITAL CATARACT
610533
WW, C2, AND COILED-COIL DOMAIN-CONTAINING 1; WWC1
Clinical Synopsis for
300602
CLARK-BARAITSER SYNDROME
Clinical Synopsis for
608088
NEUROPATHY, HEREDITARY SENSORY, TYPE I, WITH COUGH AND GASTROESOPHAGEAL
Clinical Synopsis for
610154
DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44
Clinical Synopsis for
610156
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS
Changed Entries:
139210
GROWTH-MENTAL DEFICIENCY SYNDROME OF MYHRE
147681
INTERLEUKIN 11; IL11
147683
INTERLEUKIN 13; IL13
147920
KABUKI SYNDROME
150340
LAMIN B1; LMNB1
152700
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
153432
LYMPHOCYTE-SPECIFIC PROTEIN; LSP1
153480
BANNAYAN-RILEY-RUVALCABA SYNDROME; BRRS
169500
LEUKODYSTROPHY, ADULT-ONSET, AUTOSOMAL DOMINANT
216100
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY
217980
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE
248340
MALPUECH FACIAL CLEFTING SYNDROME
256690
NEUROFACIODIGITORENAL SYNDROME
265430
PULMONARY HYPOPLASIA, PRIMARY
273750
THREE M SYNDROME
300353
V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 4; VSIG4
600129
PHOSPHODIESTERASE 4D, cAMP-SPECIFIC; PDE4D
600555
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1; STAT1
600939
INTERLEUKIN 11 RECEPTOR, ALPHA; IL11RA
601373
CHEMOKINE, CC MOTIF, RECEPTOR 5; CCR5
601728
PHOSPHATASE AND TENSIN HOMOLOG; PTEN
603352
BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5; BIRC5
604147
PITUITARY TUMOR-TRANSFORMING GENE 1; PTTG1
604672
CD209 ANTIGEN; CD209
605397
CD226 ANTIGEN; CD226
605516
CADHERIN 23; CDH23
606011
V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2; VSIG2
606120
HUMANIN
607562
INTERLEUKIN 23 RECEPTOR; IL23R
607948
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY
610532
HYPOMYELINATION AND CONGENITAL CATARACT
Clinical Synopsis for
133020
ERYTHERMALGIA, PRIMARY
Clinical Synopsis for
166300
OSTEOLYSIS, HEREDITARY, OF CARPAL BONES WITH NEPHROPATHY
Clinical Synopsis for
255800
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1
Clinical Synopsis for
256840
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL
Clinical Synopsis for
277900
WILSON DISEASE
Clinical Synopsis for
300143
MENTAL RETARDATION, X-LINKED 21; MRX21
Clinical Synopsis for
300486
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE
Clinical Synopsis for
601808
CHROMOSOME 18q DELETION SYNDROME
Clinical Synopsis for
607855
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
Clinical Synopsis for
610185
CEREBELLAR HYPOPLASIA, MENTAL RETARDATION, AND QUADRUPEDAL LOCOMOTION
October 26, 2006
New Entries:
610523
TESTIS-SPECIFIC PROTEIN 14; TSGA14
610524
HUMAN ENDOGENOUS RETROVIRUS FRD ENVELOPE PROTEIN
610525
5-PRIME-@NUCLEOTIDASE, CYTOSOLIC, IA; NT5C1A
610526
5-PRIME-@NUCLEOTIDASE, CYTOSOLIC, IB; NT5C1B
610527
THIOREDOXIN DOMAIN-CONTAINING 1; TXNDC1
610529
TUMOR SUPPRESSOR CANDIDATE 1; TUSC1
Clinical Synopsis for
300143
MENTAL RETARDATION, X-LINKED 21; MRX21
Clinical Synopsis for
300486
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE
Clinical Synopsis for
300578
CHROMOSOME Xp11.3 DELETION SYNDROME
Clinical Synopsis for
609940
MYOPATHY, LIMB-GIRDLE, WITH BONE FRAGILITY
Clinical Synopsis for
610003
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT
Clinical Synopsis for
610006
2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY
Clinical Synopsis for
610143
DEAFNESS, AUTOSOMAL RECESSIVE 62; DFNB62
Clinical Synopsis for
610153
DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49
Clinical Synopsis for
610185
CEREBELLAR HYPOPLASIA, MENTAL RETARDATION, AND QUADRUPEDAL LOCOMOTION
Changed Entries:
107269
CD44 ANTIGEN; CD44
110100
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES
126800
DUANE RETRACTION SYNDROME 1; DURS1
142994
HOMEOBOX GENE HB9; HLXB9
145420
HYPERTELORISM, TEEBI TYPE
176263
POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER
176450
CURRARINO SYNDROME
184429
SRY-BOX 2; SOX2
191440
ULNAR HYPOPLASIA
206900
MICROPHTHALMIA, SYNDROMIC 3; MCOPS3
219000
FRASER SYNDROME
222600
DIASTROPHIC DYSPLASIA
256050
ATELOSTEOGENESIS, TYPE II; AOII
277900
WILSON DISEASE
310500
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
601835
CHEMOKINE, CC MOTIF, RECEPTOR 6; CCR6
602165
TRIPARTITE MOTIF-CONTAINING PROTEIN 27; TRIM27
602218
SAL-LIKE 1; SALL1
604659
ENDOGENOUS RETROVIRAL FAMILY W, ENV-C7, MEMBER 1; ERVWE1
604962
T-CELL RECEPTOR-ASSOCIATED TRANSMEMBRANE ADAPTOR 1; TRAT1
605493
TRIPARTITE MOTIF-CONTAINING 3; TRIM3
605597
FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2
605684
TRIPARTITE MOTIF-CONTAINING PROTEIN 34; TRIM34
605988
DNA CROSS-LINK REPAIR PROTEIN 1C; DCLRE1C
606718
SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 2; SLC26A2
606882
ATPase, Cu(2+)-TRANSPORTING, BETA POLYPEPTIDE; ATP7B
607238
COPPER METABOLISM MURR1 DOMAIN-CONTAINING PROTEIN 1; COMMD1
607830
FRAS1 GENE; FRAS1
608945
FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 2; FREM2
610517
CONTACTIN-ASSOCIATED PROTEIN-LIKE 3; CNTNAP3
610523
TESTIS-SPECIFIC PROTEIN 14; TSGA14
610527
THIOREDOXIN DOMAIN-CONTAINING 1; TXNDC1
610529
TUMOR SUPPRESSOR CANDIDATE 1; TUSC1
Clinical Synopsis for
105830
ANGELMAN SYNDROME; AS
Clinical Synopsis for
134610
FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT
Clinical Synopsis for
149730
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD
Clinical Synopsis for
190300
TREMOR, HEREDITARY ESSENTIAL, 1; ETM1
Clinical Synopsis for
227280
FACIOCARDIORENAL SYNDROME
Clinical Synopsis for
245150
KEUTEL SYNDROME
Clinical Synopsis for
249100
FAMILIAL MEDITERRANEAN FEVER; FMF
Clinical Synopsis for
249600
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE
Clinical Synopsis for
250230
METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE
Clinical Synopsis for
250400
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE
Clinical Synopsis for
300534
MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED
Clinical Synopsis for
600143
CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8
Clinical Synopsis for
602471
SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL
Clinical Synopsis for
606854
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL
October 25, 2006
New Entries:
300618
PHD FINGER PROTEIN 16; PHF16
300619
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION
610514
PHD FINGER PROTEIN 17; PHF17
610515
PHD FINGER PROTEIN 15; PHF15
610516
GLYCERATE KINASE; GLYCTK
610517
CONTACTN-ASSOCIATED PROTEIN-LIKE 3; CNTNAP3
610518
CONTACTIN-ASSOCIATED PROTEIN-LIKE 4; CNTNAP4
610519
CONTACTIN-ASSOCIATED PROTEIN-LIKE 5; CNTNAP5
610520
CD300 ANTIGEN-LIKE FAMILY, MEMBER G; CD300LG
610521
POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 12; KCTD12
610522
COORDINATED EXPRESSION TO IRXA2
Clinical Synopsis for
300580
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION 2, X-LINKED; CFTD2
Clinical Synopsis for
602471
SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL
Clinical Synopsis for
608622
HYPERTENSION, DIASTOLIC, RESISTANCE TO
Changed Entries:
108720
ATELOSTEOGENESIS, TYPE I; AOI
112500
BRACHYDACTYLY, TYPE A1; BDA1
116897
CCAAT/ENHANCER-BINDING PROTEIN, ALPHA; CEBPA
118504
CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4
118507
CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 2; CHRNB2
121011
GAP JUNCTION PROTEIN, BETA-2; GJB2
122700
COUMARIN RESISTANCE
122720
CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
126455
SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, DOPAMINE),
130720
LATERAL MENINGOCELE SYNDROME
133020
ERYTHERMALGIA, PRIMARY
137750
GLAUCOMA 1, OPEN ANGLE, A; GLC1A
137760
GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET; POAG
142983
MUSCLE SEGMENT HOMEOBOX, DROSOPHILA, HOMOLOG OF, 1; MSX1
147545
INSULIN RECEPTOR SUBSTRATE 1; IRS1
153245
LYMPHOID ENHANCER-BINDING FACTOR 1; LEF1
157660
MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP
161650
NEBULIN; NEB
164761
REARRANGED DURING TRANSFECTION PROTOONCOGENE; RET
168468
PARATHYROID HORMONE RECEPTOR 1; PTHR1
176260
POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER
176876
PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 11; PTPN11
180660
POLYMERASE II, RNA, SUBUNIT A; POLR2A
182452
SOMATOSTATIN RECEPTOR 2; SSTR2
185250
MATRIX METALLOPROTEINASE 3; MMP3
186720
CD6 ANTIGEN; CD6
191160
TUMOR NECROSIS FACTOR; TNF
202700
NEUTROPENIA, SEVERE CONGENITAL; SCN
211980
LUNG CANCER
216400
COCKAYNE SYNDROME, TYPE A; CSA
220120
D-GLYCERIC ACIDEMIA
220900
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM
222600
DIASTROPHIC DYSPLASIA
226900
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4
250250
CARTILAGE-HAIR HYPOPLASIA; CHH
264480
PSEUDOTRISOMY 13 SYNDROME
310500
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
600168
MACROPHAGE STIMULATING 1 RECEPTOR; MST1R
600726
INDIAN HEDGEHOG; IHH
600807
ASTHMA, SUSCEPTIBILITY TO
601139
ZINC FINGER PROTEIN 175; ZNF175
601231
FKBP12-RAPAMYCIN COMPLEX-ASSOCIATED PROTEIN 1; FRAP1
601512
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6; STAT6
601652
MYOCILIN; MYOC
601662
ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALCAM
601682
GLAUCOMA 1, OPEN ANGLE, C; GLC1C
602432
OPTINEURIN; OPTN
602436
MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE B; MICB
602471
SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL
602893
KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 4; KLRC4
603380
LIN7, C. ELEGANS, HOMOLOG A; LIN7A
603415
SODIUM CHANNEL, VOLTAGE-GATED, TYPE IX, ALPHA SUBUNIT; SCN9A
604515
B-CELL LINKER PROTEIN; BLNK
605286
CALPAIN 10; CAPN10
606195
IROQUOIS HOMEOBOX PROTEIN 5; IRX5
606196
IROQUOIS HOMEOBOX PROTEIN 6; IRX6
606197
IROQUOIS HOMEOBOX PROTEIN 1; IRX1
606198
IROQUOIS HOMEOBOX PROTEIN 2; IRX2
606199
IROQUOIS HOMEOBOX PROTEIN 4; IRX4
606202
MEMBRANE-ASSOCIATED TRANSPORTER PROTEIN; MATP
606718
SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 2; SLC26A2
606784
GLYCOGEN SYNTHASE KINASE 3-ALPHA; GSK3A
607095
ANAUXETIC DYSPLASIA
607340
GAMMA-AMINOBUTYRIC ACID B RECEPTOR 2; GABBR2
608175
AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3
608622
HYPERTENSION, DIASTOLIC, RESISTANCE TO
608798
DFNA5 GENE; DFNA5
608874
OROFACIAL CLEFT 5
609412
EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8
609581
MOVED TO 130720
610414
NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15; NBPF15
610496
RHO GTPase-ACTIVATING PROTEIN 29; ARHGAP29
610499
RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6
610514
PHD FINGER PROTEIN 17; PHF17
610516
GLYCERATE KINASE; GLYCTK
610517
CONTACTN-ASSOCIATED PROTEIN-LIKE 3; CNTNAP3
610518
CONTACTIN-ASSOCIATED PROTEIN-LIKE 4; CNTNAP4
610519
CONTACTIN-ASSOCIATED PROTEIN-LIKE 5; CNTNAP5
Clinical Synopsis for
137920
RENAL CYSTS AND DIABETES SYNDROME
Clinical Synopsis for
245150
KEUTEL SYNDROME
Clinical Synopsis for
250460
METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS
Clinical Synopsis for
255320
MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA
Clinical Synopsis for
601152
HEREDITARY MOTOR AND SENSORY NEUROPATHY VI
Clinical Synopsis for
605839
LEIOMYOMATOSIS AND RENAL CELL CANCER, HEREDITARY
Clinical Synopsis for
606528
HOMOZYGOUS 11p15-p14 DELETION SYNDROME
October 23, 2006
New Entries:
608765
SCOLIOSIS, IDIOPATHIC 3; IS3
608798
DFNA5 GENE; DFNA5
Changed Entries:
120110
COLLAGEN, TYPE X, ALPHA-1; COL10A1
121014
GAP JUNCTION PROTEIN, ALPHA-1; GJA1
128100
DYSTONIA, TORSION, 1, AUTOSOMAL DOMINANT; DYT1
128230
DYSTONIA, DOPA-RESPONSIVE; DRD
141900
HEMOGLOBIN--BETA LOCUS; HBB
145250
HYPERPIGMENTATION, FAMILIAL PROGRESSIVE
147450
SUPEROXIDE DISMUTASE 1; SOD1
147470
INSULIN-LIKE GROWTH FACTOR II; IGF2
164200
OCULODENTODIGITAL DYSPLASIA; ODDD
176263
POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER
181800
SCOLIOSIS, IDIOPATHIC; IS1
201300
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II; HSAN2
235200
HEMOCHROMATOSIS; HFE
259050
OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND
400017
THYMOSIN, BETA-4, Y CHROMOSOME; TMSB4Y
600225
GTP CYCLOHYDROLASE I; GCH1
600487
PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 4; PCSK4
600778
CYCLIN-DEPENDENT KINASE INHIBITOR 1B; CDKN1B
600994
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5; DFNA5
601510
SREBP CLEAVAGE-ACTIVATING PROTEIN
605204
TORSIN-A; DYT1
605717
INDUCIBLE T-CELL COSTIMULATOR LIGAND; ICOSLG
606270
TOLL-LIKE RECEPTOR 10; TLR10
606634
DERMCIDIN; DCD
607354
SCOLIOSIS, IDIOPATHIC 2; IS2
608714
SYNTROPHIN, GAMMA-1; SNTG1
608798
DFNA5 GENE; DFNA5
October 20, 2006
New Entries:
610501
NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 1; NBPF1
610511
SEC23, S. CEREVISIAE, HOMOLOG OF, A; SEC23A
610512
SEC23, S. CEREVISIAE, HOMOLOG OF, B; SEC23B
610513
ATPase, TYPE 13A2; ATP13A2
Changed Entries:
113705
BREAST CANCER 1 GENE; BRCA1
124080
CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2
125220
DEFENSIN, ALPHA, 1; DEFA1
131100
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
136435
FOLLICLE-STIMULATING HORMONE RECEPTOR; FSHR
138850
GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR
142900
HOLT-ORAM SYNDROME; HOS
147781
INTERLEUKIN 4 RECEPTOR; IL4R
181450
ULNAR-MAMMARY SYNDROME; UMS
191525
URACIL-DNA GLYCOSYLASE; UNG
232300
GLYCOGEN STORAGE DISEASE II
257220
NIEMANN-PICK DISEASE, TYPE C1; NPC1
300193
HIGH MOBILITY GROUP BOX 3; HMGB3
300490
SH2 DOMAIN PROTEIN 1A; SH2D1A
601620
T-BOX 5; TBX5
601621
T-BOX 3; TBX3
602726
CHLORIDE CHANNEL 6; CLCN6
604522
DEFENSIN, ALPHA, 3; DEFA3
605004
GLYCOGEN SYNTHASE KINASE 3-BETA; GSK3B
605554
CD244 ANTIGEN; CD244
606784
GLYCOGEN SYNTHASE KINASE 3-ALPHA; GSK3A
606800
GLUCOSIDASE, ALPHA, ACID; GAA
607623
NPC1 GENE; NPC1
610511
SEC23, S. CEREVISIAE, HOMOLOG OF, A; SEC23A
October 19, 2006
New Entries:
610510
AURORA BOREALIS
Changed Entries:
114210
S100 CALCIUM-BINDING PROTEIN A4; S100A4
124010
CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 4; CYP3A4
124015
CYTOCHROME P450 OXIDOREDUCTASE; POR
138079
GLUCOKINASE; GCK
142410
TRANSCRIPTION FACTOR 1; TCF1
145900
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS
147740
INTERLEUKIN 3; IL3
151385
RUNT-RELATED TRANSCRIPTION FACTOR 1; RUNX1
154545
LECTIN, MANNOSE-BINDING, SOLUBLE, 2; MBL2
176915
PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP2CA
176990
S100 CALCIUM-BINDING PROTEIN, BETA; S100B
180660
POLYMERASE II, RNA, SUBUNIT A; POLR2A
182452
SOMATOSTATIN RECEPTOR 2; SSTR2
185800
SYMPHALANGISM, PROXIMAL; SYM1
191170
TUMOR PROTEIN p53; TP53
191525
URACIL-DNA GLYCOSYLASE; UNG
201750
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO APPARENT COMBINED P450C17
250220
METAPHYSEAL CHONDRODYSPLASIA, CONGENITAL LETHAL
253310
LETHAL CONGENITAL CONTRACTURE SYNDROME 1
600281
HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A
601047
CAVEOLIN 1; CAV1
601146
GROWTH/DIFFERENTIATION FACTOR 5; GDF5
601769
VITAMIN D RECEPTOR; VDR
602466
SPROUTY, DROSOPHILA, HOMOLOG OF, 2; SPRY2
602926
SYNTAXIN-BINDING PROTEIN 1; STXBP1
603072
AURORA KINASE A; AURKA
603243
AUTOCRINE MOTILITY FACTOR RECEPTOR; AMFR
603507
LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6; LRP6
603795
LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR-ALPHA FACTOR; LITAF
604147
PITUITARY TUMOR-TRANSFORMING GENE 1; PTTG1
605253
NEUROPATHY, CONGENITAL HYPOMYELINATING
605523
TRANSDUCER OF ERBB2, 1; TOB1
606359
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A
607358
AUTOIMMUNE REGULATOR; AIRE
607393
HRPT2 GENE; HRPT2
607752
URACIL-DNA GLYCOSYLASE 2; UNG2
607984
SPROUTY, DROSOPHILA, HOMOLOG OF, 4; SPRY4
608736
SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 14; SLC39A14
609366
SH2 DOMAIN-BINDING PROTEIN 1; SH2BP1
609708
LIPOPROTEIN LIPASE; LPL
610453
HEPARAN-ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE; HGSNAT
October 18, 2006
New Entries:
610475
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2
610489
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1
610498
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2
610504
PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM
610505
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3
610506
PAF1 RNA POLYMERASE II-ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF;
610507
LEO1 RNA POLYMERASE II ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF;
610508
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE VII; MODY7
610509
RESISTANCE TO INHIBITORS OF CHOLINESTERASE 3, C. ELEGANS, HOMOLOG
Changed Entries:
104300
ALZHEIMER DISEASE; AD
104760
AMYLOID BETA A4 PRECURSOR PROTEIN; APP
114840
CARBOXYL-ESTER LIPASE; CEL
120355
MATRIX METALLOPROTEINASE 8; MMP8
125520
CAYLER CARDIOFACIAL SYNDROME
139320
GNAS COMPLEX LOCUS; GNAS
143200
WAGNER SYNDROME 1; WGN1
154780
MARSHALL SYNDROME
156225
LAMININ, ALPHA-2; LAMA2
160980
CARNEY COMPLEX, TYPE 1; CNC1
165240
GLI-KRUPPEL FAMILY MEMBER 3; GLI3
168450
PARATHYROID HORMONE; PTH
188830
PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, ALPHA; PRKAR1A
191525
URACIL-DNA GLYCOSYLASE; UNG
201300
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II; HSAN2
219080
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH
246570
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME
300286
KRUPPEL-LIKE FACTOR 8; KLF8
310500
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
600047
ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2
600943
COLLAGEN-BINDING PROTEIN 2; CBP2
601653
EYES ABSENT 1; EYA1
601769
VITAMIN D RECEPTOR; VDR
602568
METHIONINE SYNTHASE REDUCTASE; MTRR
603301
KRUPPEL-LIKE FACTOR 11; KLF11
604723
Ts TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TSFM
604961
PHOSPHODIESTERASE 11A; PDE11A
606391
MATURITY-ONSET DIABETES OF THE YOUNG; MODY
606594
SET DOMAIN-CONTAINING PROTEIN 7; SETD7
607240
SET DOMAIN-CONTAINING PROTEIN 8; SETD8
607393
HRPT2 GENE; HRPT2
607752
URACIL-DNA GLYCOSYLASE 2; UNG2
607855
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
608620
HSN2 GENE; HSN2
609060
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1
609204
MITOCHONDRIAL RIBOSOMAL PROTEIN S16: MRPS16
609366
SH2 DOMAIN-BINDING PROTEIN 1; SH2BP1
609812
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE VIII, WITH EXOCRINE DYSFUNCTION;
610475
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2
610504
PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM
610506
PAF1 RNA POLYMERASE II-ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF;
610509
RESISTANCE TO INHIBITORS OF CHOLINESTERASE 3, C. ELEGANS, HOMOLOG
Clinical Synopsis for
143200
WAGNER SYNDROME 1; WGN1
October 17, 2006
New Entries:
610500
ANKYRIN REPEAT AND KH DOMAIN-CONTAINING PROTEIN 1; ANKHD1
610502
RETICULON 4-INTERACTING PROTEIN 1; RTN4IP1
610503
CHROMOSOME 16 OPEN READING FRAME 5; C16ORF5
Changed Entries:
113505
BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF
138275
GLUTAMIC ACID DECARBOXYLASE 2; GAD2
143023
RAS ASSOCIATION DOMAIN FAMILY, MEMBER 7; RASSF7
182340
ATPase, Na+/K+ TRANSPORTING, ALPHA-2 POLYPEPTIDE; ATP1A2
219090
CUSHING DISEASE, PITUITARY
601510
SREBP CLEAVAGE-ACTIVATING PROTEIN
602695
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12
602974
AQUAPORIN 7; AQP7
603483
EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 3; EIF4EBP3
604386
ZINC FINGER TRANSCRIPTION FACTOR TRPS1; TRPS1
604472
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13; TNFSF13
604882
NEUROGENIN 3; NEUROG3
604907
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13B; TNFRSF13B
605244
CARNEY COMPLEX, TYPE II; CNC2
606624
NEUROGENIN 2; NEUROG2
607173
PROTEASOME 26S SUBUNIT, NON-ATPase, 14; PSMD14
608231
RAS ASSOCIATION DOMAIN FAMILY, MEMBER 8; RASSF8
610222
RAS AND RAB INTERACTOR 2; RIN2
610399
TRANSMEMBRANE PROTEASE, SERINE 11E; TMPRSS11E
610414
NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15; NBPF15
610448
CHILBLAIN LUPUS
610499
RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6
October 16, 2006
New Entries:
300617
BRCA1/BRCA2-CONTAINING COMPLEX, SUBUNIT 3; BRCC3
610494
IQ MOTIF- AND WD REPEATS-CONTAINING 1; IQWD1
610495
HOM-TES-103 GENE
610496
RHO GTPase-ACTIVATING PROTEIN 29; ARHGAP29
610497
BRAIN AND REPRODUCTIVE ORGAN-EXPRESSED PROTEIN; BRE
610499
RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6
Changed Entries:
108300
STICKLER SYNDROME, TYPE I; STL1
112262
BONE MORPHOGENETIC PROTEIN 4; BMP4
113705
BREAST CANCER 1 GENE; BRCA1
118423
CHIMERIN 1; CHN1
118661
CHONDROITIN SULFATE PROTEOGLYCAN 2; CSPG2
120140
COLLAGEN, TYPE II, ALPHA-1; COL2A1
123900
VILLIN 2; VIL2
137240
GASTRIC INHIBITORY POLYPEPTIDE; GIP
143200
WAGNER SYNDROME 1; WGN1
152390
ARACHIDONATE 5-LIPOXYGENASE; ALOX5
179617
RAD51, S. CEREVISIAE, HOMOLOG OF; RAD51
300023
RHO GTPase-ACTIVATING PROTEIN 4; ARHGAP4
300116
MATURE T-CELL PROLIFERATION 1; MTCP1
300118
RHO GTPase-ACTIVATING PROTEIN 6; ARHGAP6
300617
BRCA1/BRCA2-CONTAINING COMPLEX, SUBUNIT 3; BRCC3
306700
HEMOPHILIA A
600185
BREAST CANCER 2 GENE; BRCA2
600303
RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RAPGEF1
601593
BRCA1-ASSOCIATED RING DOMAIN 1; BARD1
602632
PODOCALYXIN-LIKE; PODXL
602680
RHO GTPase-ACTIVATING PROTEIN 5; ARHGAP5
602732
RHO GTPase-ACTIVATING PROTEIN 1; ARHGAP1
602857
CHIMERIN 2; CHN2
603594
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 4; TNFSF4
604258
DELETED IN LIVER CANCER 1; DLC1
605370
RHO GTPase-ACTIVATING PROTEIN 26; ARHGAP26
606523
SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 1; SRGAP1
606524
SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2; SRGAP2
606525
SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 3; SRGAP3
606553
SOLUTE CARRIER FAMILY 9, ISOFORM 3, REGULATORY FACTOR 2; SLC9A3R2
606748
COACTOSIN-LIKE PROTEIN 1; COTL1
608293
RHO GTPase-ACTIVATING PROTEIN 17; ARHGAP17
609405
RHO GTPase-ACTIVATING PROTEIN 8; ARHGAP8
609508
STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR
609568
RHO GTPase-ACTIVATING PROTEIN 20; ARHGAP20
609746
RHO GTPase-ACTIVATING PROTEIN 10; ARHGAP10
609870
RHO GTPase-ACTIVATING PROTEIN 21; ARHGAP21
610351
MEK1 SUPPRESSOR 1
610352
MEK1 SUPPRESSOR 2
610492
SLAIN MOTIF FAMILY, MEMBER 2; SLAIN2
610494
IQ MOTIF- AND WD REPEATS-CONTAINING 1; IQWD1
610496
RHO GTPase-ACTIVATING PROTEIN 29; ARHGAP29
October 13, 2006
New Entries:
300616
LEUCINE ZIPPER PROTEIN 4; LUZP4
610488
TETRATRICOPEPTIDE REPEAT DOMAIN 9; TTC9
610490
PURPLE ACID PHOSPHATASE, LONG FORM
610491
SLAIN MOTIF FAMILY, MEMBER 1; SLAIN1
610492
SLAIN MOTIF FAMILY, MEMBER 2; SLAIN2
610493
DIX DOMAIN-CONTAINING PROTEIN 1; DIXDC1
Changed Entries:
103500
TIETZ SYNDROME
104311
PRESENILIN 1; PSEN1
114180
CALMODULIN 1; CALM1
120160
COLLAGEN, TYPE I, ALPHA-2; COL1A2
125647
DESMOPLAKIN; DSP
154700
MARFAN SYNDROME; MFS
156845
MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF
176270
PRADER-WILLI SYNDROME; PWS
179520
RAS-RELATED PROTEIN 1A; RAP1A
179540
RAS-RELATED PROTEIN 2A; RAP2A
179541
RAS-RELATED PROTEIN 2B; RAP2B
187300
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;
225320
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM
235730
MOWAT-WILSON SYNDROME
300290
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA
300401
PROTEOLIPID PROTEIN 1; PLP1
300461
ORNITHINE CARBAMOYLTRANSFERASE; OTC
306700
HEMOPHILIA A
600005
MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, TRANSACTIVATOR; MHC2TA
601692
TRANSFORMING GROWTH FACTOR, BETA-INDUCED, 68-KD; TGFBI
602489
KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED
602612
CAMPTODACTYLY, MYOPIA, AND FIBROSIS OF THE MEDIAL RECTUS MUSCLE OF
603381
FILAMIN B; FLNB
605802
ZINC FINGER HOMEOBOX 1B; ZFHX1B
605946
METAPHYSEAL DYSPLASIA, BRAUN-TINSCHERT TYPE
606419
PRECURSOR mRNA-PROCESSING FACTOR 31, S. CEREVISIAE, HOMOLOG OF; PRPF31
606478
PROTECTION OF TELOMERES 1; POT1
607086
AORTIC ANEURYSM, FAMILIAL THORACIC 1
609449
NUDE, A. NIDULANS, HOMOLOG OF, 1; NDE1
609546
UBIQUITIN-SPECIFIC PROTEASE 29; USP29
610126
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6
610381
CONE-ROD DYSTROPHY 11
610421
KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED
610493
DIX DOMAIN-CONTAINING PROTEIN 1; DIXDC1
October 12, 2006
New Entries:
610483
AGAMMAGLOBULINEMIA, MICROCEPHALY, AND SEVERE DERMATITIS
610484
PROLINE-RICH SYNAPSE-ASSOCIATED PROTEIN-INTERACTING PROTEIN 1
610485
LOSS OF HETEROZYGOSITY, CHROMOSOME 3, REGION 2, GENE A; LOH3CR2A
610486
LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4; LRRC4
610487
KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED
Changed Entries:
101200
APERT SYNDROME
103070
ADENYLATE CYCLASE 8; ADCY8
103071
ADENYLATE CYCLASE 2; ADCY2
103072
ADENYLATE CYCLASE 1; ADCY1
108985
SVEINSSON CHORIORETINAL ATROPHY; SCRA
114500
COLORECTAL CANCER; CRC
118502
CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 2; CHRNA2
120290
COLLAGEN, TYPE XI, ALPHA-2; COL11A2
125853
DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM
133780
EXUDATIVE VITREORETINOPATHY 1; EVR1
153700
MACULAR DYSTROPHY, VITELLIFORM; VMD
153870
MACULAR DYSTROPHY, CONCENTRIC ANNULAR
163200
NEVUS SEBACEUS OF JADASSOHN
163730
NITRIC OXIDE SYNTHASE 2A; NOS2A
182940
NEURAL TUBE DEFECTS
191390
ULCERATIVE COLITIS, SUSCEPTIBILITY TO
193235
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI
194050
WILLIAMS-BEUREN SYNDROME; WBS
215150
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED
257270
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B
266600
INFLAMMATORY BOWEL DISEASE 1; IBD1
300476
CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3
300614
AUDITORY NEUROPATHY, X-LINKED, 1, WITH PERIPHERAL NEUROPATHY
301040
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED;
309801
MICROPHTHALMIA, SYNDROMIC 7; MCOPS7
310500
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
600037
ORTHODENTICLE, DROSOPHILA, HOMOLOG OF, 2; OTX2
600045
DNA DAMAGE-BINDING PROTEIN 1; DDB1
600291
ADENYLATE CYCLASE 3; ADCY3
600292
ADENYLATE CYCLASE 4; ADCY4
600293
ADENYLATE CYCLASE 5; ADCY5
600294
ADENYLATE CYCLASE 6; ADCY6
600385
ADENYLATE CYCLASE 7; ADCY7
600807
ASTHMA, SUSCEPTIBILITY TO
601276
ZINC FINGER PROTEIN 177; ZNF177
601401
MYELOID LEUKEMIA FACTOR 2; MLF2
601424
3-@OXOACID CoA TRANSFERASE 1; OXCT1
602489
KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED
602929
LOSS OF HETEROZYGOSITY, CHROMOSOME 11, REGION 2, GENE A; LOH11CR2A
602932
MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 7; SMAD7
603037
LEFT-RIGHT DETERMINATION FACTOR 1; LEFTY1
603045
LOSS OF HETEROZYGOSITY, CHROMOSOME 18, REGION 1; LOH18CR1
603075
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1
603104
CARBOXYPEPTIDASE N, POLYPEPTIDE 2, 83-KD; CPN2
603302
ADENYLATE CYCLASE 9; ADCY9
603513
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE
604096
GLUTAMATE RECEPTOR, METABOTROPIC, 6; GRM6
604213
CHUDLEY-MCCULLOUGH SYNDROME
604519
INFLAMMATORY BOWEL DISEASE 3; IBD3
605300
ADAPTOR PROTEIN CONTAINING PH AND SH2 DOMAINS
607076
PROTEASE INHIBITOR 15; PI15
607335
BESTROPHIN 2; BEST2
607336
BESTROPHIN 4; BEST4
607337
BESTROPHIN 3; BEST3
607485
FRONTOTEMPORAL DEMENTIA, UBIQUITIN-POSITIVE
607854
BESTROPHIN 1; BEST1
607948
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY
608161
MACULAR DYSTROPHY, VITELLIFORM, ADULT-ONSET
608329
CHROMOSOME 11 OPEN READING FRAME 9; C11ORF9
608505
MOVED TO 225750
608603
CANCER-RELATED GENE, LIVER, 2
609532
HEPATITIS C VIRUS, SUSCEPTIBILITY TO
609622
SHORT QT SYNDROME 3; SQT3
610247
ESOPHAGITIS, EOSINOPHILIC
610273
PHOSPHATIDYLINOSITOL GLYCAN, CLASS M; PIGM
610274
PHOSPHATIDYLINOSITOL GLYCAN, CLASS V; PIGV
610275
PHOSPHATIDYLINOSITOL GLYCAN, CLASS W; PIGW
610293
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY
610324
3-@OXOACYL-ACP SYNTHASE, MITOCHONDRIAL; OXSM
610331
HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 6; HES6
610353
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 4
610362
RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX-LIKE 1; RAXL1
610371
SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER
610374
DIABETES MELLITUS, TRANSIENT NEONATAL, 2
610379
WEST NILE VIRUS, SUSCEPTIBILITY TO
610380
AORTIC ANEURYSM, FAMILIAL THORACIC 5
610386
BTB/POX DOMAIN-CONTAINING PROTEIN 7; BTBD7
610424
HEPATITIS B VIRUS, SUSCEPTIBILITY TO
610474
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME
610476
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11
610478
RETINAL CONE DYSTROPHY 4; RCD4
October 11, 2006
New Entries:
610460
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY
610477
TRANSMEMBRANE PROTEASE, SERINE 9; TMPRSS9
610479
SRF-DEPENDENT TRANSCRIPTION REGULATION-ASSOCIATED PROTEIN; SRFBP1
610480
LEM DOMAIN-CONTAINING PROTEIN 1; LEMD1
610481
SH2 DOMAIN-CONTAINING PROTEIN D; SHD
610482
SH2 DOMAIN-CONTAINING PROTEIN E; SHE
Changed Entries:
102560
ACTIN, GAMMA-1; ACTG1
102630
ACTIN, BETA; ACTB
104760
AMYLOID BETA A4 PRECURSOR PROTEIN; APP
120577
COMPLEMENT COMPONENT 1, q SUBCOMPONENT, RECEPTOR 1; C1QR1
130050
EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT
131230
ANNEXIN A5; ANXA5
138190
SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER
163730
NITRIC OXIDE SYNTHASE 2A; NOS2A
169610
PEMPHIGUS VULGARIS, FAMILIAL
180860
SILVER-RUSSELL SYNDROME; SRS
187680
THIOPURINE S-METHYLTRANSFERASE; TPMT
190181
TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE I; TGFBR1
190182
TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II; TGFBR2
191160
TUMOR NECROSIS FACTOR; TNF
248190
HYPOMAGNESEMIA, RENAL, WITH OCULAR INVOLVEMENT
254940
MYOPATHY, CONGENITAL NONPROGRESSIVE, WITH MOEBIUS SEQUENCE AND ROBIN
256600
NEUROAXONAL DYSTROPHY, INFANTILE; INAD1
300300
BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK
300394
TAFAZZIN; TAZ
302060
BARTH SYNDROME; BTHS
600073
LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2; LRP2
600289
MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14
600385
ADENYLATE CYCLASE 7; ADCY7
600970
MYOSIN VI; MYO6
602081
SPEECH-LANGUAGE DISORDER 1; SPCH1
602382
PHOSPHOLIPASE D1, PHOSPHATIDYLCHOLINE-SPECIFIC; PLD1
603301
TRANSFORMING GROWTH FACTOR-BETA-INDUCIBLE EARLY GROWTH RESPONSE 2;
603372
THYROID-STIMULATING HORMONE RECEPTOR; TSHR
603604
PHOSPHOLIPASE A2, GROUP VI; PLA2G6
605072
GAIP C-TERMINUS-INTERACTING PROTEIN 1; GIPC1
605317
FORKHEAD BOX P2; FOXP2
605857
RAS HOMOLOG GENE FAMILY, MEMBER Q; ARHQ
606409
ITCHY, MOUSE, HOMOLOG OF; ITCH
607844
LEM DOMAIN-CONTAINING PROTEIN 3; LEMD3
609192
LOEYS-DIETZ SYNDROME; LDS
610168
FURLONG SYNDROME: FS
Clinical Synopsis for
309801
MICROPHTHALMIA, SYNDROMIC 7; MCOPS7
October 10, 2006
New Entries:
610471
VASOHIBIN 2; VASH2
610472
ACYLTRANSFERASE-LIKE 2; AYTL2
610473
LYSOPHOSPHATIDYLGLYCEROL ACYLTRANSFERASE 1; LPGAT1
610474
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME
610476
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11
610478
RETINAL CONE DYSTROPHY 4; RCD4
Changed Entries:
107970
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1
117000
CENTRAL CORE DISEASE OF MUSCLE
120436
MutL, E. COLI, HOMOLOG OF, 1; MLH1
125645
DESMOCOLLIN 2; DSC2
134934
FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3
138030
GLUCAGON; GCG
164840
V-MYC AVIAN MYELOCYTOMATOSIS VIRAL-RELATED ONCOGENE, NEUROBLASTOMA-DERIVED;
179040
MOVED TO 179050
180901
RYANODINE RECEPTOR 1; RYR1
182135
5-@HYDROXYTRYPTAMINE RECEPTOR 2A; HTR2A
248190
HYPOMAGNESEMIA, RENAL, WITH OCULAR INVOLVEMENT
248250
HYPOMAGNESEMIA, PRIMARY
252930
MUCOPOLYSACCHARIDOSIS TYPE IIIC
300056
HOLOCYTOCHROME C SYNTHASE; HCCS
309801
MICROPHTHALMIA, SYNDROMIC 7; MCOPS7
600778
CYCLIN-DEPENDENT KINASE INHIBITOR 1B; CDKN1B
601728
PHOSPHATASE AND TENSIN HOMOLOG; PTEN
602372
ZONADHESIN; ZAN
602712
AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 2; APBA2
603369
CYCLIN-DEPENDENT KINASE INHIBITOR 2C; CDKN2C
603452
MOVED TO 602712
604605
KALIRIN; KALRN
604723
Ts TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TSFM
604934
TUBULIN-SPECIFIC CHAPERONE E; TBCE
605723
PROGRAMMED CELL DEATH 1 LIGAND 2; PDCD1LG2
606478
PROTECTION OF TELOMERES 1; POT1
606639
MITOCHONDRIAL ELONGATION FACTOR G1; GFM1
607145
DYSTROBREVIN-BINDING PROTEIN 1; DTNBP1
608171
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 4; CACNA2D4
608309
PTEN-INDUCED PUTATIVE KINASE 1; PINK1
609011
VASOHIBIN 1; VASH1
609060
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1
610036
CLAUDIN 19; CLDN19
610453
HEPARAN-ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE; HGSNAT
October 9, 2006
New Entries:
610468
INTERFERON-INDUCED PROTEIN 44; IFI44
610469
ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-2 SUBUNIT; AP3M2
610470
TRANSFER RNA PHOSPHOTRANSFERASE 1; TRPT1
Changed Entries:
114500
COLORECTAL CANCER; CRC
147470
INSULIN-LIKE GROWTH FACTOR II; IGF2
147586
INTERFERON-GAMMA-INDUCIBLE PROTEIN 16; IFI16
163200
NEVUS SEBACEUS OF JADASSOHN
168461
CYCLIN D1; CCND1
174900
JUVENILE POLYPOSIS SYNDROME; JPS
175100
ADENOMATOUS POLYPOSIS OF THE COLON; APC
176730
INSULIN; INS
180901
RYANODINE RECEPTOR 1; RYR1
191290
TYROSINE HYDROXYLASE; TH
194554
ZINC FINGER PROTEIN 45; ZNF45
194555
ZINC FINGER PROTEIN 224; ZNF224
228250
FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY
300120
CHROMOSOME X OPEN READING FRAME 6; CXORF6
300171
MYOTUBULARIN-RELATED PROTEIN 1; MTMR1
305620
FRONTOMETAPHYSEAL DYSPLASIA; FMD
310400
MYOTUBULAR MYOPATHY 1; MTM1
516060
ATP SYNTHASE 6; MTATP6
600879
NUCLEAR RESPIRATORY FACTOR 1; NRF1
600993
MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 4; SMAD4
601158
MITOGEN-ACTIVATED PROTEIN KINASE 8; MAPK8
601206
POU DOMAIN, CLASS 2, ASSOCIATING FACTOR 1; POU2AF1
601742
TRIPARTITE MOTIF-CONTAINING PROTEIN 28; TRIM28
601767
HUNTINGTIN-INTERACTING PROTEIN 1; HIP1
601781
MOVED TO 194554
602279
POLYADENYLATE-BINDING PROTEIN, NUCLEAR, 1; PABPN1
602372
ZONADHESIN; ZAN
602614
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7; MAP3K7
604373
CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2
606681
NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX
606955
MOVED TO 194555
606956
ZINC FINGER PROTEIN 256; ZNF256
610366
ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-1 SUBUNIT; AP3M1
610469
ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-2 SUBUNIT; AP3M2
610470
TRANSFER RNA PHOSPHOTRANSFERASE 1; TRPT1
October 6, 2006
New Entries:
610464
G PROTEIN-COUPLED RECEPTOR 156; GPR156
610466
LIMB EXPRESSION 1, MOUSE, HOMOLOG OF; LIX1
610467
PROTEIN TYROSINE PHOSPHATASE-LIKE (PROLINE INSTEAD OF CATALYTIC ARGININE),
Changed Entries:
107741
APOLIPOPROTEIN E; APOE
107910
CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1
134370
COMPLEMENT FACTOR H; CFH
138470
COMPLEMENT FACTOR B; CFB
139210
GROWTH-MENTAL DEFICIENCY SYNDROME OF MYHRE
139300
GYNECOMASTIA, HEREDITARY
139320
GNAS COMPLEX LOCUS; GNAS
153700
MACULAR DYSTROPHY, VITELLIFORM; VMD
162200
NEUROFIBROMATOSIS, TYPE I; NF1
171050
ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1
188000
THROMBOCYTOPENIA 2; THC2
217000
COMPLEMENT COMPONENT 2 DEFICIENCY
218600
BALLER-GEROLD SYNDROME; BGS
220210
DANDY-WALKER-LIKE MALFORMATION WITH ATRIOVENTRICULAR SEPTAL DEFECT
231000
GAUCHER DISEASE, TYPE III
261540
PETERS-PLUS SYNDROME
300377
DYSTROPHIN; DMD
600010
INSULINOMA-ASSOCIATED 1; INSM1
602366
INTEGRIN-LINKED KINASE; ILK
602958
SERUM/GLUCOCORTICOID-REGULATED KINASE; SGK
603075
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1
603273
TUMOR PROTEIN p73-LIKE; TP73L
603571
VANIN 2; VNN2
603934
COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1; CARM1
604167
CCCTC-BINDING FACTOR; CTCF
604401
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 6
604817
CARBOHYDRATE SULFOTRANSFERASE 5; CHST5
605112
TROPOMODULIN 3; TMOD3
605566
RETICULON 4 RECEPTOR; RTN4R
605571
PIWI-LIKE 1; PIWIL1
606463
GLUCOSIDASE, BETA, ACID; GBA
606847
TCOF1 GENE; TCOF1
607093
5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
607340
GAMMA-AMINOBUTYRIC ACID B RECEPTOR 2; GABBR2
607854
BESTROPHIN 1; BEST1
607856
CINGULIN-LIKE 1; CGNL1
608221
MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE-LIKE; MASTL
608270
THREONINE ASPARTASE 1; TASP1
608795
PHOSPHOLIPASE C, DELTA-3; PLCD3
609803
ANKYRIN AND ARMADILLO REPEATS-CONTAINING PROTEIN; ANKAR
610149
LOC387715 GENE
610308
UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE-LIKE; B3GALTL
610464
G PROTEIN-COUPLED RECEPTOR 156; GPR156
610467
PROTEIN TYROSINE PHOSPHATASE-LIKE (PROLINE INSTEAD OF CATALYTIC ARGININE),
October 5, 2006
New Entries:
300615
BRUNNER SYNDROME
610461
RETICULON 4 RECEPTOR-LIKE 1; RTN4RL1
610462
RETICULON 4 RECEPTOR-LIKE 2; RTN4RL2
610463
NOGOB RECEPTOR
610465
FLJ20920 GENE
Changed Entries:
120920
MEMBRANE COFACTOR PROTEIN; MCP
122920
MOVED TO 304110
134370
COMPLEMENT FACTOR H; CFH
139320
GNAS COMPLEX LOCUS; GNAS
143100
HUNTINGTON DISEASE; HD
147683
INTERLEUKIN 13; IL13
147781
INTERLEUKIN 4 RECEPTOR; IL4R
147811
INTERLEUKIN 1 RECEPTOR, TYPE II; IL1R2
157140
MICROTUBULE-ASSOCIATED PROTEIN TAU; MAPT
158375
MUCIN 7, SALIVARY; MUC7
160900
DYSTROPHIA MYOTONICA 1
161561
INTERLEUKIN 12B; IL12B
189971
E2F TRANSCRIPTION FACTOR 1; E2F1
227400
FACTOR V DEFICIENCY
235400
HEMOLYTIC-UREMIC SYNDROME, ATYPICAL; aHUS
300119
INTERLEUKIN 13 RECEPTOR, ALPHA-1; IL13RA1
305360
MEMBRANE PROTEIN, PALMITOYLATED 1; MPP1
309850
MONOAMINE OXIDASE A; MAOA
309860
MONOAMINE OXIDASE B; MAOB
600018
OPIOID RECEPTOR, MU-1; OPRM1
600515
PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 12; P2RY12
600807
ASTHMA, SUSCEPTIBILITY TO
602145
PROLIFERATION-ASSOCIATED 2G4, 38-KD; PA2G4
602590
p21/CDC42/RAC1-ACTIVATED KINASE 1; PAK1
602975
MOVED TO 608833
604046
OXIDATIVE STRESS-RESPONSIVE 1; OXSR1
604475
RETICULON 4; RTN4
605232
PROTEIN KINASE, LYSINE-DEFICIENT 1; WNK1
605377
DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK
605566
RETICULON 4 RECEPTOR; RTN4R
607114
A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 33; ADAM33
607928
WHIRLIN; WHRN
608593
COMPLEMENT FACTOR H-RELATED 5; CFHR5
608833
CHROMOSOME 20 OPEN READING FRAME 41; C20ORF41
609496
MOVED TO 609814
609685
CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7-LIKE; CDCA7L
609814
COMPLEMENT FACTOR H DEFICIENCY
October 4, 2006
New Entries:
610459
PROLINE-RICH PROTEIN 13; PRR13
Changed Entries:
125240
CD55 ANTIGEN; CD55
134371
COMPLEMENT FACTOR H-RELATED 1; CFHR1
143465
ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD
146732
INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IGFBP3
146735
INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 6; IGFBP6
147267
INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 3; ITPR3
160900
DYSTROPHIA MYOTONICA 1
163500
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2
164831
LEUKEMIA VIRAL BMI-1 ONCOGENE, MOUSE, HOMOLOG OF; BMI1
180380
RHODOPSIN; RHO
181500
SCHIZOPHRENIA; SCZD
182389
SODIUM CHANNEL, NEURONAL TYPE I, ALPHA SUBUNIT; SCN1A
182390
SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, ALPHA SUBUNIT; SCN2A
182391
SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, ALPHA SUBUNIT; SCN3A
188060
THROMBOSPONDIN I; THBS1
222100
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
257270
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL RECESSIVE
600163
SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A
600235
SODIUM CHANNEL, VOLTAGE-GATED, TYPE I, BETA SUBUNIT; SCN1B
600702
SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A
601219
MOVED TO 182390
601298
MOVED TO 102576
603022
E4F TRANSCRIPTION FACTOR 1; E4F1
603415
SODIUM CHANNEL, VOLTAGE-GATED, TYPE IX, ALPHA SUBUNIT; SCN9A
603967
SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, ALPHA SUBUNIT; SCN4A
604096
GLUTAMATE RECEPTOR, METABOTROPIC, 6; GRM6
604233
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS; GEFS+
604385
SODIUM CHANNEL, VOLTAGE-GATED, TYPE XI, ALPHA SUBUNIT; SCN11A
604427
SODIUM CHANNEL, VOLTAGE-GATED, TYPE X, ALPHA SUBUNIT; SCN10A
604687
PROSTAGLANDIN D2 RECEPTOR; PTGDR
604933
MutY, E. COLI, HOMOLOG OF; MUTYH
605446
RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN; RPGRIP1
607745
SEIZURES, BENIGN FAMILIAL NEONATAL-INFANTILE
608214
SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, BETA SUBUNIT; SCN3B
610444
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3
October 3, 2006
New Entries:
610444
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3
610445
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1
Changed Entries:
117141
CENTROMERIC PROTEIN C1; CENPC1
126420
TOPOISOMERASE, DNA, I; TOP1
134820
FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA
134850
FIBRINOGEN, G GAMMA POLYPEPTIDE; FGG
139330
GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE
141800
HEMOGLOBIN--ALPHA LOCUS 1; HBA1
141850
HEMOGLOBIN--ALPHA LOCUS 2; HBA2
141900
HEMOGLOBIN--BETA LOCUS; HBB
163500
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2
176914
PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP1CC
176930
COAGULATION FACTOR II; F2
180072
PHOSPHODIESTERASE 6B, cGMP-SPECIFIC, ROD, BETA; PDE6B
180380
RHODOPSIN; RHO
180690
RNA, U2 SMALL NUCLEAR; RNU2
182465
SON DNA-BINDING PROTEIN; SON
203285
MOVED TO 608233
224120
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE I
227400
FACTOR V DEFICIENCY
230800
GAUCHER DISEASE, TYPE I
268000
RETINITIS PIGMENTOSA; RP
300071
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A
300600
ALBINISM, OCULAR, TYPE II; OA2
300614
AUDITORY NEUROPATHY, X-LINKED, 1, WITH PERIPHERAL NEUROPATHY
310500
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1; CSNB1
311800
PHOSPHOGLYCERATE KINASE 1; PGK1
400010
DEAD/H BOX 3, Y-LINKED; DBY
600044
THROMBOPOIETIN; THPO
600047
ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2
601065
ALANYL-tRNA SYNTHETASE; AARS
601445
NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 9; NDUFB9
601772
H2A HISTONE FAMILY, MEMBER X; H2AFX
603401
ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1
604685
HOMEOBOX A2; HOXA2
605093
LYMPHOCYTE ADAPTOR PROTEIN
605281
DEAD/H BOX 4; DDX4
606027
CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 1; CPSF1
607005
GEM-ASSOCIATED PROTEIN 5
607058
GAP JUNCTION PROTEIN, ALPHA-9
607465
CODANIN 1; CDAN1
608212
LRG47, MOUSE, HOMOLOG OF
608233
HERMANSKY-PUDLAK SYNDROME 2; HPS2
609812
DIABETES AND PANCREATIC EXOCRINE DYSFUNCTION
610445
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1
October 2, 2006
New Entries:
300614
AUDITORY NEUROPATHY, X-LINKED, 1, WITH PERIPHERAL NEUROPATHY
Changed Entries:
120150
COLLAGEN, TYPE I, ALPHA-1; COL1A1
122920
MOVED TO 304100
134350
COMPLEMENT FACTOR D; CFD
145420
HYPERTELORISM, TEEBI TYPE
152700
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
171300
PHEOCHROMOCYTOMA
180849
RUBINSTEIN-TAYBI SYNDROME; RSTS
191160
TUMOR NECROSIS FACTOR; TNF
191540
URATE OXIDASE; UOX
193300
VON HIPPEL-LINDAU SYNDROME; VHL
231100
HEMOCHROMATOSIS, NEONATAL
259420
OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE
266200
PYRUVATE KINASE DEFICIENCY OF RED CELLS
300457
NHS GENE; NHS
300530
KAWASAKI DISEASE
300614
AUDITORY NEUROPATHY, X-LINKED, 1, WITH PERIPHERAL NEUROPATHY
302350
NANCE-HORAN SYNDROME; NHS
304110
CRANIOFRONTONASAL SYNDROME; CFNS
561000
RIBOSOMAL RNA, MITOCHONDRIAL, 12S; MTRNR1
600576
GATA-BINDING PROTEIN 4; GATA4
601656
GATA-BINDING PROTEIN 6; GATA6
601769
VITAMIN D RECEPTOR; VDR
601847
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2; PFIC2
601973
RETINOIC ACID RECEPTOR RESPONDER 2; RARRES2
602351
CHEMOKINE-LIKE RECEPTOR 1; CMKLR1
603201
ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 11; ABCB11
604457
NUCLEAR BODY PROTEIN SP110; SP110
604895
T-BOX 21; TBX21
606412
BSND GENE
606463
GLUCOSIDASE, BETA, ACID; GBA
606598
GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1; GDAP1
607114
A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 33; ADAM33
607948
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY
608340
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A
609712
PYRUVATE KINASE, LIVER AND RED BLOOD CELL; PKLR
Disclaimer
|
Write to the Help Desk
|
Privacy Policy
NCBI
|
NLM
|
NIH